Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-30
2011-08-30
Seaman, D (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S167000, C546S180000
Reexamination Certificate
active
08008497
ABSTRACT:
The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator.The R1represents a hydrogen atom or a lower alkyl group; R2represents a hydrogen atom or a lower alkyl group; R3and R4may be the same or different and represent a hydrogen atom or a lower alkyl group; R5represents a hydrogen atom or a lower alkyl group; R6represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR8—, —S(O)2— and the like; R7and/or R8may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; Z represents a benzene ring or a heterocyclic ring; and P represents 0, 1, 2 or 3.
REFERENCES:
patent: 5688808 (1997-11-01), Jones et al.
patent: 5688810 (1997-11-01), Jones et al.
patent: 6852719 (2005-02-01), Liu et al.
patent: 2004/0116455 (2004-06-01), Bekkali et al.
patent: 2007/0254917 (2007-11-01), Higuchi et al.
patent: 2009/0298827 (2009-12-01), Matsuda et al.
patent: 2009/0326009 (2009-12-01), Matsuda et al.
patent: 2010/0056504 (2010-03-01), Matsuda et al.
patent: 1 944 290 (2008-07-01), None
patent: 10-510840 (1998-10-01), None
patent: 2002-193955 (2002-07-01), None
patent: WO 96/19458 (1996-06-01), None
patent: WO 96/19458 (1996-06-01), None
patent: WO 2004/018429 (2004-03-01), None
patent: WO 2006/019716 (2006-02-01), None
patent: WO 2007/032556 (2007-03-01), None
patent: 2009/111632 (2008-09-01), None
patent: WO 2008/111632 (2008-09-01), None
U.S. Appl. No. 11/992,088, filed Mar. 14, 2008, Confirmation No. 4161.
Supplementary European Search Report dated Nov. 4, 2010 in European Patent Application No. 07 83 1813.
Hajime Nawata, Sougou Rinsyou, “New horizon of glucocorticoid therapy in 21stcentury,” 54(7), pp. 1915-2076 (2005).
Ku, Yi-Yin; Grieme, et al., “Asymmetric Synthesis of A-240610.0 via a new Atropselective Approach for Axially Chiral Biaryls with Chirality transfer,” Journal of The American Chemical Society, vol. 124, 2002, pp. 4282-4286.
Sougou Rinsyou, 54(7), 1951-2076 (2005) and English translation of identified portions of pp. 1952-2073.
U.S. Appl. No. 12/312,392, filed May 7, 2009, Confirmation No. 8349.
U.S. Appl. No. 12/312,396, filed May 7, 2009, Confirmation No. 5788.
Kato Masatomo
Kobayashi Sachiko
Matsuda Mamoru
Mori Toshiyuki
Nagatsuka Masato
Holtz, Holtz, Goodman & Chick, P.C.
Santen Pharmaceutical Co. Ltd.
Seaman D
LandOfFree
1,2-dihydroquinoline derivative having (substituted phenyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2-dihydroquinoline derivative having (substituted phenyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2-dihydroquinoline derivative having (substituted phenyl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656238